在日本一般人口中的QT间隔延长和痴呆症:西山研究
Taeko Mashima1,2, Emi Oishi1,3,4, Takanori Honda1,4
1Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Journal of atherosclerosis and thrombosis
|July 24, 2025
概括
延长心率校正的QT (QTc) 间隔与血管痴呆 (VaD) 的风险增加有关. 这种心电图的发现可能有助于识别患有VaD风险较高的个体,有助于初级预防策略.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 老年学是一门学科.
背景情况:
- 心血管健康对认知功能至关重要.
- 电心电图 (ECG) 参数可以提供有关神经疾病风险的见解.
- 纵向研究对于了解痴呆症发展至关重要.
研究的目的:
- 为了检查心率校正QT (QTc) 间隔延长与痴呆症风险之间的关联.
- 调查与痴呆症亚型的关系,包括血管痴呆症 (VaD) 和阿尔茨海默病 (AD).
- 利用来自日本社区的长期前性数据.
主要方法:
- 这是一项为期24年的前性纵向研究,对1082名60岁以上没有痴呆症的日本居民进行了长期研究.
- 通过12导心电图测量QTc间隔,使用Bazett方程进行校正.
- 考克斯比例危险模型用于评估与QTc间隔水平相关的风险 (≤401毫秒,402-417毫秒,418-439毫秒,≥440毫秒).
主要成果:
- 在延长QTc间隔和增加VaD风险之间发现了显著的关联.
- 随着QTc间隔的延长,VaD的危险比率增加,HR为2.64 (95% CI为1.49至4.68),QTc≥440毫秒与≤401毫秒相比 (趋势的p=0.01).
- 在QTc间隔和全因痴呆症或AD风险之间没有观察到显著的关联.
结论:
- QTc延长可以作为一种潜在的指标,用于识别患有VaD的高风险个体.
- 基于心电图的QTc测量可以帮助预防血管痴呆症.
- 需要进一步研究QTc延长和VaD之间的机制联系.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.1K
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.1K
相关概念视频
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
59
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
59
01:30Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262